11th International Congress on Drug Therapy in HIV Infection (HIV11)

11th International Congress on Drug Therapy in HIV Infection (HIV11)

November 11-15, 2012, Glasgow

HIV11: Dolutegravir Remains Effective for Treatment-experienced People with Multidrug-resistant HIV

The investigational HIV integrase inhibitor dolutegravir, which has shown comparable or superior efficacy to widely used drugs in clinical trials to date, works well for people with highly resistant HIV, including virus with mutations conferring resistance to other drugs in its class, researchers reported at the 11th International Congress on Drug Therapy in HIV Infection (HIV11) this week in Glasgow.alt

Read more: